Core Laboratories (NYSE:CLB) Releases Q4 2026 Earnings Guidance

Core Laboratories (NYSE:CLB) issued an update on its fourth quarter 2026 earnings guidance on Friday. The company provided EPS guidance of 0.120-0.200 for the period, compared to the consensus EPS estimate of 0.190. The company issued revenue guidance of $128.5 million-$134.5 million, compared to the consensus revenue estimate of $134.2 million.

Wall Street Analyst Weigh In

CLB has been the subject of several recent analyst reports. Weiss Ratings upgraded shares of Core Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday. Johnson Rice upgraded Core Laboratories from a “hold” rating to a “buy” rating and set a $21.00 target price on the stock in a research report on Thursday, August 13th. Finally, Wall Street Zen raised Core Laboratories from a “sell” rating to a “hold” rating in a research note on Saturday, August 1st. One research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $21.00.

Core Laboratories Stock Up 1.0%

NYSE:CLB traded up $0.10 during trading hours on Friday, reaching $10.50. The company had a trading volume of 165,241 shares, compared to its average volume of 591,650. The company has a quick ratio of 1.55, a current ratio of 2.12 and a debt-to-equity ratio of 0.41. The firm has a market cap of $481.74 million, a price-to-earnings ratio of 27.63, a P/E/G ratio of 2.09 and a beta of 1.14. The business’s 50-day simple moving average is $11.03 and its two-hundred day simple moving average is $13.96. Core Laboratories has a twelve month low of $9.13 and a twelve month high of $20.36.

Core Laboratories (NYSE:CLB) last announced its quarterly earnings data on Wednesday, October 28th. The oil and gas company reported $0.16 earnings per share for the quarter, meeting the consensus estimate of $0.16. The firm had revenue of $132.08 million for the quarter, compared to analyst estimates of $131.87 million. Core Laboratories had a net margin of 3.42% and a return on equity of 9.01%. The business’s quarterly revenue was down 1.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.22 earnings per share. On average, equities analysts expect that Core Laboratories will post 0.56 earnings per share for the current year.

Core Laboratories Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, November 30th. Shareholders of record on Monday, November 9th will be issued a $0.01 dividend. The ex-dividend date is Monday, November 9th. This represents a $0.04 annualized dividend and a yield of 0.4%. Core Laboratories’s dividend payout ratio is presently 7.14%.

Core Laboratories Company Profile

Core Laboratories N.V. (NYSE: CLB) is a global provider of proprietary reservoir description and production enhancement services and products for the energy industry. The company helps oil and natural gas producers evaluate reservoirs, improve well performance, and optimize the recovery of hydrocarbons.

Its reservoir description activities include geological and geochemical analysis, petrophysical services, core and fluid analysis, and laboratory testing used to characterize subsurface formations.